|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2003-11-24
|
|
pubmed:abstractText |
The aim of this study was to describe the National Institutes of Health's experience initiating an islet isolation and transplantation center, including descriptions of our first six recipients, and lessons learned.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus,
http://linkedlifedata.com/resource/pubmed/chemical/daclizumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3288-95
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14633816-Adult,
pubmed-meshheading:14633816-Antibodies, Monoclonal,
pubmed-meshheading:14633816-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:14633816-Blood Glucose,
pubmed-meshheading:14633816-Diabetes Mellitus, Type 1,
pubmed-meshheading:14633816-Drug Therapy, Combination,
pubmed-meshheading:14633816-Female,
pubmed-meshheading:14633816-Follow-Up Studies,
pubmed-meshheading:14633816-Humans,
pubmed-meshheading:14633816-Hypoglycemia,
pubmed-meshheading:14633816-Immunoglobulin G,
pubmed-meshheading:14633816-Immunosuppression,
pubmed-meshheading:14633816-Immunosuppressive Agents,
pubmed-meshheading:14633816-Islets of Langerhans Transplantation,
pubmed-meshheading:14633816-Middle Aged,
pubmed-meshheading:14633816-Postoperative Complications,
pubmed-meshheading:14633816-Reproducibility of Results,
pubmed-meshheading:14633816-Sirolimus,
pubmed-meshheading:14633816-Tacrolimus,
pubmed-meshheading:14633816-Time Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
|
|
pubmed:affiliation |
Transplantation and Autoimmunity Branch, National Institutes of Health/Department of Health and Human Services, Bethesda, Maryland, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
